Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain

NCT04713189 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Breakthrough Cancer Pain

Interventions

DRUG: Inhaled fentanyl aerosol
DRUG: Placebo

Sponsor

Lee's Pharmaceutical Limited